United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - fusidic acid - cutaneous cream - 20mg/1gram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - fusidic acid - cutaneous cream - 20mg/1gram

Canada - English - Health Canada

taro pharmaceuticals inc - fusidic acid (fusidic acid hemihydrate) - cream - 2% - fusidic acid (fusidic acid hemihydrate) 2%

Australia - English - Department of Health (Therapeutic Goods Administration)

leo pharma pty ltd - sodium fusidate, quantity: 20 mg/g - ointment - excipient ingredients: white soft paraffin; cetyl alcohol; wool fat; liquid paraffin - skin lesions primarily and secondarily infected with staphylococci, e.g. abscesses, boils, furunculosis, impetigo, folliculitis, hidradenitis, pyoderma, sycosis barbae, otitis externa.

Australia - English - Department of Health (Therapeutic Goods Administration)

leo pharma pty ltd - sodium fusidate, quantity: 250 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; titanium dioxide; lactose monohydrate; crospovidone; hypromellose; microcrystalline cellulose; purified talc; magnesium stearate; dl-alpha-tocopherol - treatment of localised, as well as generalised, staphylococcal infections caused by susceptible organisms. in severe infections, deep-seated infections, infections due to methicillin-resistant staphylococci or when prolonged therapy may be required, fucidin must be given concurrently with other anti-staphylococcal antibiotic therapy.

Israel - English - Ministry of Health

dexcel ltd, israel - fusidic acid - cream - fusidic acid 20 mg/g - fusidic acid - fusidic acid - local treatment of skin infections due to sensitive strains of staphylococus aureus.

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - fusidic acid 2%{relative} - topical cream - 2% w/w - active: fusidic acid 2%{relative} excipient: cetomacrogol 1000 cetostearyl alcohol liquid paraffin methyl hydroxybenzoate propyl hydroxybenzoate propylene glycol purified water white soft paraffin - indicated either alone or in combination with systemic therapy, in the treatment of primary and indicated for secondary skin infections caused by sensitive strains of staphylococcus aureus, streptococcus spp and corynebacterium minutissimum. primary skin infections that may be expected to respond to treatment with fusidic acid applied topically include: impetigo contagiosa, superficial folliculitis, sycosis barbae, paronychia and erythrasma; also such secondary skin infections as infected eczematoid dermatitis, infected contact dermatitis and infected cuts / abrasions.

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - sodium fusidate 2%{relative} - topical ointment - 2% w/w - active: sodium fusidate 2%{relative} excipient: liquid paraffin white soft paraffin - indicated either alone or in combination with systemic therapy, in the treatment of primary and secondary skin infections caused by sensitive strains of staphylococcus aureus, streptococcus spp and corynebacterium minutissimum. primary skin infections that may be expected to respond to treatment with fusidic acid applied topically include: impetigo contagiosa, superficial folliculitis, sycosis barbae, paronychia and erythrasma; also such secondary skin infections as infected eczematoid dermatitis, infected contact dermatitis and infected cuts / abrasions.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

komedic sdn bhd - sodium fusidate -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pahang pharmacy sdn. bhd. - fusidic acid; betamethasone valerate -